as on March 5, 2026 at 9:31 pm IST
Day's Low
Day's High
0.66%
Downside
1.52%
Upside
52 Week's Low
52 Week's High
0.66%
Downside
60.33%
Upside
as on March 5, 2026 at 4:01 pm IST
Market Cap
₹2,645.94 Cr
Return on Equity (ROE)
11.26
PE Ratio (TTM)
19.21
Return on capital employed (ROCE)
15.21
Industry PE ratio
44.83
Beta (LTM)
0.62
P/B Ratio
3.1
Dividend Yield
0.08
PEG Ratio
76.84
Quarterly Earnings Growth YOY
3.38
EPS (TTM)
24.63
Sector
Chemicals
Book Value
214.12
Technical Analysis
Bearish
View Technical Analysis
as on March 5, 2026 at 4:01 pm IST
Rossari Biotech in the last 5 years
Lowest (19.11x)
March 4, 2026
Today (19.21x)
March 5, 2026
Industry (44.83x)
March 5, 2026
Highest (90.67x)
September 15, 2021
Today’s Price to Earnings Ratio: 19.21x
Compare market cap, revenue, PE, and other key metrics of Rossari Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 2,645.94 | -10.53% | 0.58 | 136 | 2,080 | |
| NA | 6,364.00 | 7.08% | 0.56 | 585 | 7,892 | |
| HOLD | 11,172.37 | 33.84% | 0.80 | 434 | 8,404 | |
| BUY | 11,407.09 | 76.58% | 0.76 | 184 | 2,101 | |
| HOLD | 5,003.68 | -1.1% | 0.00 | 125 | 2,662 |
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
80.00%
Buy
20.00%
Hold
0.00%
Sell
Search interest for Rossari Biotech Ltd Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Rossari Biotech.
Rossari Biotech Ltd’s net profit jumped 3.38% since last year same period to ₹32.77Cr in the Q3 2025-2026. On a quarterly growth basis, Rossari Biotech Ltd has generated -11.14% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Rossari Biotech Ltd has declared dividend of ₹0.50 per share on 25 Apr 2025 - translating a dividend yield of 0.21%.
Read More about DividendsCheck stock indices that include Rossari Biotech.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
![]()
Mutual Funds have increased holdings from 13.27% to 13.47% in Dec 2025 quarter
Retail Holding Up
![]()
Retail Investor have increased holdings from 10.95% to 11.26% in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Anupam Rasayan India Ltd has given 68.0% return, outperforming this stock by 91.1%
Against Peers
![]()
In the last 1 year, Anupam Rasayan India Ltd has given 65.7% return, outperforming this stock by 92.2%
Price Dip
![]()
In the last 3 months, ROSSARI stock has moved down by -21.2%
Promoter Holding Down
![]()
Promoters have decreased holdings from 68.17% to 68.16% in Dec 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 588.18 Cr → 582.59 Cr (in ₹), with an average decrease of 1.0% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 2.69% to 2.33% in Dec 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 36.88 Cr → 32.77 Cr (in ₹), with an average decrease of 11.1% per quarter
| Organisation | Rossari Biotech Ltd |
| Headquarters | Mumbai |
| Industry | Chemicals |
| CEO | Edward Menezes |
| E-voting on shares | Click here to vote |
Rossari Biotech share price today stands at ₹477.75 as on at the close of the market. Rossari Biotech share today touched a day high of ₹485 and a low of ₹474.6.
Rossari Biotech touched a 52 week high of ₹766 and a 52 week low of ₹474.6. Rossari Biotech share price today i.e. is closed at ₹477.75, which is -37.63% down from its 52 week high and 0.66% up from its 52 week low.
Rossari Biotech market capitalisation is ₹2,645.94 Cr as on .
To buy Rossari Biotech shares, you need to follow these steps:
Rossari Biotech trading volume is 24.25K as on . This means that 24.25K shares of Rossari Biotech were bought and sold on the stock market during today's trading session.